Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

TICRR serves as a prognostic biomarker in lung adenocarcinoma with implications in RNA epigenetic modification, DDR pathway, and RNA metabolism.

Autor: Zheng X; The School of Clinical Medicine, Fujian Medical University, Fuzhou, China.; Department of Respiratory and Critical Illness Medicine, the First Hospital of Putian City, Putian, China., Han L; Beijing ChosenMed Clinical Laboratory Co. Ltd., Beijing, China., Guan J; The School of Clinical Medicine, Fujian Medical University, Fuzhou, China.; Department of Cardiothoracic Surgery, the First Hospital of Putian City, Putian, China., Chen C; The School of Clinical Medicine, Fujian Medical University, Fuzhou, China.; Department of Respiratory and Critical Illness Medicine, the First Hospital of Putian City, Putian, China., Zhang Y; Beijing ChosenMed Clinical Laboratory Co. Ltd., Beijing, China., Zhang J; Beijing ChosenMed Clinical Laboratory Co. Ltd., Beijing, China., Zhang Y; Beijing ChosenMed Clinical Laboratory Co. Ltd., Beijing, China., Liu S; Beijing ChosenMed Clinical Laboratory Co. Ltd., Beijing, China., Su J; Beijing ChosenMed Clinical Laboratory Co. Ltd., Beijing, China., Liu M; Beijing ChosenMed Clinical Laboratory Co. Ltd., Beijing, China., Huang H; The School of Clinical Medicine, Fujian Medical University, Fuzhou, China.; Department of Pathology, the First Hospital of Putian City, Putian, China.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 Dec 13; Vol. 13, pp. 1274439. Date of Electronic Publication: 2023 Dec 13 (Print Publication: 2023).